Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results
Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.
How this was made
The 30-second read
Why it matters
Q1 FY2027 shows strong growth and profitability improvement, with medical as the primary driver and gross margin expanding due to favorable product and geographic mix. Management reiterates flat-to-modest full-year revenue growth, attributing outlook to timing of large production platform orders and uncertainty in certain clean energy sectors.
Market read
Traders can reassess near-term expectations for SOTK based on the medical-led mix shift, margin expansion, and the reiterated full-year revenue outlook tied to production platform shipment timing.
What to watch
Full-year revenue is guided flat to modestly higher, and backlog is down versus fiscal year-end, implying near-term execution and shipment timing risk.
Background
Sono-Tek is a precision ultrasonic coating systems developer, with strategy emphasizing higher-value production systems and advanced technology markets, particularly medical devices.
Ticker impact
Sono-Tek reported Q1 FY2027 net sales up 10% to $5.66M, gross margin up to 57%, and net income up to $741K.
Near-term bias positive, but upside may be capped by flat-to-modest full-year revenue outlook and shipment-timing dependence.
The article provides multiple concrete quarterly datapoints (sales, margins, income) plus guidance language that highlights variability from large production platform order timing.
Market effects
Supports read-across that ultrasonic coating demand is strengthening in medical device manufacturing, while clean-energy exposure remains volatile.
No specific regional macro catalyst beyond stated demand across the U.S., Europe, and Asia.
Limited broader market relevance; primarily company-specific medical mix and production-system adoption.
Counterpoint
Margin expansion may not persist each quarter given management’s explicit caveat that gross margin may not be representative going forward.
Key entities
- companySono-Tek Corporation
Nasdaq-listed ultrasonic coating systems manufacturer reporting Q1 FY2027 results and FY2027 outlook.
- personSteve Harshbarger
CEO and President, cited medical demand and mix as drivers of margin expansion and profitability.
- personDr. Christopher L. Coccio
Executive Chairman, commented on long-term strength of the ultrasonic coating technology platform.
